The aim of our study was to evaluate whether the blood pressure (BP) response to chronic inhibition of NO synthase (NOS) is exaggerated in young rats, which were reported to develop a more pronounced salt hypertension than the adult ones. The enhanced BP rise in immature rats subjected to excess salt intake might be due either to a generally increased reactivity in immature organisms to these stimuli or to a greater impairment of NO bioavailability that accompanies the development of salt hypertension. To determine between the two alternatives, we have compared the hypertensive response and the extent of NOS inhibition in immature (4-week-old) and adult (12-week-old) male Wistar rats which were treated with N G -nitro-L-arginine methyl ester (L-NAME, 40 mg/kg of body mass per day) for 4 weeks. BP and NOS activity in the aorta, left ventricle and kidney were determined at the end of the experiment. It should be noted that chronic L-NAME treatment caused a similar degree of NOS inhibition in both age groups (irrespective of tissue examined). There was no significant difference in BP elevation between young and adult animals chronically treated with L-NAME. A strong negative correlation between NOS activity and BP level was observed in separate groups of normotensive controls and L-NAME hypertensive rats. Thus the BP of both normotensive and hypertensive animals seems to be inversely proportional to the production of NO. It can be concluded that there was the same BP rise in both age groups of L-NAME-treated rats in which a similar degree of NOS inhibition was disclosed. This suggests that the altered NO bioavailability (but not the generally exaggerated reactivity to hypertensive stimuli) is the cause of exaggerated hypertensive response observed in immature rats exposed to excess salt intake.
INTRODUCTION
There is no doubt that the development of hypertension in immature animals represents a very complex interaction between obligatory ontogenetic changes and facultative alterations induced by the hypertensive stimulus or resulting from the hypertensive process itself. This is true not only for the development of experimental hypertension induced by environmental stimuli (such as excess salt intake) [1] , but also for genetic hypertension developing under the influence of various pharmacological or nutritional interventions applied at different stages of the ontogeny [2] .
Salt-dependent forms of experimental hypertension represent a classical example of exaggerated hypertensive response of weanling or pre-pubertal rats to hypertensive stimuli involving high salt intake [1] . Our previous studies demonstrated the age-dependent participation of particular vasoactive systems in the pathogenesis and/or maintenance of salt-dependent hypertension elicited in either young or adult rats. Thus sympathetic nervous system and digoxin-like factor play a more important role in salt hypertension elicited in immature rats [3, 4] , whereas reserve pressor systems (such as angiotensin II, vasopressin or endothelin-1) are considerably activated when salt hypertension is induced in adulthood [4] [5] [6] . Recently we have reported that NO bioavailability is reduced in young compared with adult salt hypertensive Dahl rats [7] , because NO seems to be inactivated by the enhanced superoxide production in young salt hypertensive animals [8] . This alteration could be responsible for the exaggerated hypertensive response of immature rats to excess salt intake, although such an idea is in contrast with the previous hypothesis proposing that the enhanced hypertensive response of young animals is due to increased vulnerability of the immature organism to the hypertensive process, resulting in greater end-organ damage (especially in the kidney and vascular system) [1, 9] .
Although N G -nitro-l-arginine methyl ester (l-NAME)-induced hypertension is usually considered as a special hypertensive model which is distinctly different from all the other forms of experimental hypertension, there are quite surprising similarities with salt hypertension. It is evident from the comparison of salt hypertensive Dahl rats with animals subjected to chronic inhibition of NO synthase (NOS) that both hypertensive models are characterized by enhanced contribution of the sympathetic nervous system to blood pressure (BP) maintenance [8, [10] [11] [12] and both forms of hypertension can be prevented by early sympathectomy [13, 14] . In addition, chronic treatment with angiotensin-convertingenzyme inhibitors or angiotensin type 1 receptor blockers attenuates not only the development of l-NAME hypertension [15, 16] , but also salt hypertension in Dahl rats [17, 18] . In both cases, central reninangiotensin-system blockade and consequent lowering of sympathetic tone seem to be of high importance for the antihypertensive action of these drugs [19] [20] [21] [22] . Finally, salt hypertension of Dahl rats is also accompanied by considerable alterations of NO production and/or NO bioavailability [8, 23, 24] . These similarities might justify our attempt to use some data obtained in l-NAME hypertensive rats for the clarification of mechanisms responsible for the age-dependent BP response to excess salt intake.
To test the causes for the above mentioned higher susceptibility of immature rats, we have studied hypertensive response and NOS activity in weanling and adult rats subjected to chronic NOS inhibition by l-NAME administration. Under the assumption that a similar degree of NO synthesis inhibition would be achieved in both age groups of l-NAME-treated animals, a higher BP response in young rats would favour the generally increased susceptibility of the immature organism to hypertensive stimuli, whereas a similar BP response in both age groups would support the importance of changes in NO bioavailability for the magnitude of hypertensive response.
METHODS
Male Wistar rats (Institute of Physiology AS CR, Prague, Czech Republic) were housed under standard laboratory conditions (temperature 23 + − 1
• C, 12-h light-dark cycle), drank tap water ad libitum and were fed standard ST1 diet (containing 1 % NaCl). At the age of either 4 weeks (young groups) or 12 weeks (adult groups) the animals were randomly assigned to control or experimental groups. Half of the animals in each age group began to be treated with l-NAME (40 mg/kg of body mass per day, administered in the drinking fluid) for 4 weeks. At the end of the experiment, BP was measured by the direct puncture of carotid artery (using P23 Db Statham pressure transducer and Hewlett-Packard HP 7754A recorder) under light ether anaesthesia.
After the killing of the animals by exsanguination, aorta, heart, kidney and liver were excised, weighed and homogenized for the determination of NOS activity and GSH content. NOS activity was determined in crude homogenates of left ventricle, aorta and kidney by measuring the formation of l-
3 H]arginine (Amersham), as previously described by Bredt and Snyder [25] with minor modifications. Briefly, 50 µl of crude homogenate of the left ventricle (7.5 mg of wet tissue), aorta (5 mg of wet tissue) or kidney (5 mg of wet tissue) were incubated in the presence of 50 mmol/l Tris/HCl, pH 7.4, containing 1 µmol/l l-[
3 H]arginine (specific activity 5 GBq/mmol, approx. 100 000 d.p.m.), 0.5 mg/ml calmodulin, 0.5 mmol/l β-NADPH, 250 µmol/l tetrahydrobiopterin, 4 µmol/l FAD, 4 µmol/l flavin mononucleotide and 1 mmol/l Ca 2+ , in a total volume of 100 µl. After a 10-min incubation at 37
• C, the reaction was stopped (by adding 0.02 M Hepes containing 2 mM EDTA, 2 mM EGTA and 1 mM l-[
3 H]citrulline), the samples were centrifuged, and supernatants were applied to 1-ml Dowex 50WX-8 columns (Na + form). l-[ 3 H]Citrulline was eluted with 2 ml of water and radioactivity was determined by liquid scintillation counting. NOS activity was expressed as pkat per g of protein.
GSH content was determined in heart, kidney and liver. Immediately after excising the organs, concentrations of GSH were determined spectrophotometrically by the method of Ellman [26] . Briefly, samples of tissues were mixed with 0.5 vol. of ice-cold 5 % sulphosalicylic acid, and after centrifugation at 12 000 g for 15 min the concentration of GSH was determined in the acid-soluble fractions.
Figure 1 Systolic (SBP), mean arterial (MAP) and diastolic (DBP) BP of young and adult L-NAME hypertensive rats and their normotensive controls
Results are expressed as the means + − S.E.M. Asterisks indicate significant differences (P < 0.05) from age-matched controls.
All procedures and experimental protocols, which were approved by the Ethical Committee of the Institute of Physiology AS CR, conform to the European Convention on Animal Protection. Table 1 Body mass and relative organ mass in young and adult male Wistar rats subjected to L-NAME administration for 4 weeks
Results are expressed as the means + − S.E.M. Significantly different (P < 0.05) from : *age-matched controls and †corresponding young group.
Young
Adult Controls (n = 9) L-NAME (n = 9) Controls (n = 9) L-NAME (n = Results are expressed as the means + − S.E.M. The statistical differences were evaluated by one-way analysis of variance followed by the least-significant difference test. Linear correlation analysis was used to evaluate the association of BP with NOS activity. P < 0.05 was considered as significant. Figure 1 shows that chronic administration of l-NAME caused similar BP elevation in young and adult rats (18 % in young and 20 % in adult animals). No significant cardiac or renal hypertrophy was found in either age group of hypertensive rats ( Table 1) . Chronic l-NAME treatment reduced NOS activity in the aorta, left ventricle and kidney of hypertensive rats from both age groups (Table 2 ). The degree of NOS inhibition tended to be more pronounced in adult hypertensive rats (aorta, − 47 %; left ventricle, − 54 %; kidney, − 45 %) compared with young hypertensive rats (aorta, − 36 %, left ventricle, − 45 %; kidney, − 36 %), but these agedependent differences did not reach significance, except for the left ventricle (P < 0.02). The concentration of GSH was significantly decreased by chronic l-NAME treatment only in the kidney (Table 2) , and this reduction was again similar in both age groups of hypertensive animals (young, − 28 %; adult, − 23 %).
RESULTS

Table 3 Relationship between BP and absolute (a) or relative (b) values of NOS activity in normotensive controls and hypertensive rats subjected to L-NAME administration for 4 weeks
The relationships are expressed as correlation coefficients (r). Significantly different from zero: *P < 0.05, **P < 0.01 and ***P < 0.001. LV, left ventricle. In both normotensive and hypertensive rats BP correlated negatively with NOS activity in particular organs; the relationships being usually more significant for systolic rather than diastolic BP (Table 3) . Furthermore, the slope of this relationship was always substantially steeper in hypertensive than in normotensive animals ( Figure 2 ). In agreement with the recent study by Ishii et al. [27] , NOS activity was significantly higher in the kidney and aorta of adult control animals. We have therefore expressed our results in percentage of values found in the respective tissue of age-matched controls. It is evident from Table 3 that these relative values of NOS activity were also closely related to the BP of control and hypertensive rats, indicating that even small changes in NO production are accompanied by substantial changes of BP.
The exceptionally close correlation between values of NOS activity determined in heart, aorta and kidney of our animals ( Figure 3 ) made it possible to estimate the average NOS activity in all organs examined. Using this value we were able to document that BP was indeed inversely proportional to NOS activity not only in the experimental group, but also in the control animals ( Table 3 and Figure 4) . 
DISCUSSION
Our present study revealed a similar level of NOS inhibition by chronic l-NAME treatment in immature The average value of NOS activity was determined in various organs and is expressed as a percentage of the age-matched controls.
and adult rats, which was accompanied by the same BP rise in both age groups, supporting the hypothesis that the magnitude of hypertensive response is related to the degree of NOS inhibition observed. Furthermore, we have demonstrated that BP correlated inversely with NOS activity. Surprisingly, this was true not only in l-NAME-treated rats, but also in normotensive controls. The steeper slope of this relationship in hypertensive than in normotensive animals indicates greater sensitivity to antihypertensive action of NO in NO-deficient hypertensive rats.
Since NO stimulates synthesis of the major antioxidant thiol glutathione in vitro, we have studied the relationship between NO synthesis and GSH concentration in kidney and liver. The concentration of GSH was significantly decreased in the kidney of both age groups of l-NAMEtreated rats, but there were no changes in its concentration in the liver of these hypertensive animals. Our finding of lowered GSH production in rats with NO-deficient hypertension is in agreement with a previous report by Levonen et al. [28] on the reduced activity of γ -glutamylcysteine synthase, a rate-limiting enzyme of GSH synthesis, in l-NAME-treated rats. Interestingly, this decrease in enzyme activity was further enhanced by high salt intake.
Although chronic treatment with l-NAME elicited a similar degree of hypertension in young and adult Wistar rats, it remains an open question whether both age groups would not differ in the consequences of high BP. In the present study we have not observed any marked agedependent differences in organ hypertrophy, but there might be a different response to treatment discontinuation. Morton et al. [29] described self-sustaining hypertension in weanling Wistar rats treated with a high dose of l-NAME (100 mg/kg of body mass per day) for 3 weeks. However, the persistence of hypertension after the discontinuation of l-NAME administration was less evident if their animals were treated with only 40 mg/kg of body mass per day (as in our present study). This will be a subject of our further work, because self-sustaining forms of experimental hypertension still represent an important research topic. It was Dahl and co-workers [30] who reported that 6 weeks (but not 2 weeks) of excess salt intake can induce a permanent hypertension in weanling Dahl rats, which persists even if the rats are again switched to a low salt intake. Thus the l-NAME dose and the duration of treatment will carefully be considered in our forthcoming experiments.
The results might help us to evaluate the mechanisms of exaggerated BP response of young rats to excess salt intake. It is evident from the present study that young Wistar rats do not respond to a given degree of NO deficiency by a greater BP rise than the adult animals. Consequently, a decreased NO bioavailability in young (but not in adult) salt hypertensive Dahl rats [7] should be considered as an important mechanism involved in the enhanced hypertensive response of salt-loaded immature rats. This is in good agreement with our present observation that, irrespective of age, BP level is closely related to NO production (as reflected by the inverse relationship of BP to NOS activity in various organs). This relationship should be tested by measuring NOS activity in salt-dependent forms of experimental hypertension, especially in Dahl rats.
Future experiments in l-NAME hypertensive rats should pay attention not only to the total NOS activity, but also to the activity of its particular isoforms, because Luvara et al. [31] described a considerable elevation of inducible (i)NOS mRNA and protein expression in the aorta of l-NAME hypertensive rats, whereas endothelial (e)NOS expression remained unaltered compared with the normotensive controls. Our recent results obtained using the acute administration of aminoguanidine (a specific iNOS inhibitor) strongly support a major iNOS upregulation in adult l-NAME-induced hypertensive rats (O. Pecháňová, Z. Dobešová, J.Čejka, J. Kuneš and J. Zicha, unpublished work). The forthcoming study should also determine the expression of various NOS isoforms (namely eNOS and iNOS) in both age groups of l-NAME hypertensive rats. The attention should also be focused to the production of reactive oxygen species (and to their interaction with NO) in young and adult animals subjected to chronic l-NAME treatment, because superoxide anions lower NO bioavailability [32] , whereas H 2 O 2 increases endothelial NO production in a time-and dose-dependent manner [33] .
In conclusion, chronic l-NAME administration elicited a similar degree of NOS inhibition and similar BP rise in immature and adult rats. In both age groups, BP was inversely proportional to NOS activity determined in various organs (such as kidney, heart and aorta). It is important to note that, although NO exerts significant BP control in normotensive animals, they are less sensitive to its action compared with NO-deficient rats chronically treated with l-NAME.
